Skip to main content
. 2019 Dec 11;2019(12):CD006281. doi: 10.1002/14651858.CD006281.pub5

2. Oral riluzole versus placebo (Russman 2003).

  Riluzole Placebo
Number of participants randomised 7 3
Number (%) of participants evaluable for analysis 7 (100%) 3 (100%)
Number of participants (%) who died during the 12‐month study 4 (57%) 3 (100%)
Median age at death (months)* 17 8
Range of ages at death (months)* 5‐25 6‐13
Adverse events 0 0

*Among the children who died during the 12‐month study. Three of the seven children treated with riluzole were alive at 30, 48 and 64 months' follow‐up.